Improving Chronic Disease Outcomes Through Medication Therapy Management in Federally Qualified Health Centers

Introduction: Appropriate management of chronic diseases, including proper use of medications, can lead to better disease control, decrease disease-related complications, and improve overall health. Pharmacists have been shown to positively affect chronic disease outcomes through medication therapy...

Full description

Saved in:
Bibliographic Details
Published in:Journal of primary care & community health 2017-10, Vol.8 (4), p.324-331
Main Authors: Rodis, Jennifer L., Sevin, Alexa, Awad, Magdi H., Porter, Brianne, Glasgow, Kyle, Hornbeck Fox, Carrie, Pryor, Barbara
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Antihypertensive Agents - therapeutic use
Blood Pressure
Chronic illnesses
Clinical outcomes
Community Health Centers
Diabetes
Diabetes Mellitus - drug therapy
Diabetes Mellitus - metabolism
Drug therapy
Drugs
Female
Glycated Hemoglobin A - metabolism
Health facilities
Humans
Hypertension
Hypertension - drug therapy
Hypoglycemic Agents - therapeutic use
Male
Management development programmes
Middle Aged
Outcome Assessment (Health Care)
Patient Education as Topic
Patients
Pharmacists
Pharmacy Service, Hospital - methods
Pilot Projects
Pilot Studies
Prospective Studies
Quality Improvement
Referral and Consultation
Self Care
Selfmanagement
Underserved populations
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction: Appropriate management of chronic diseases, including proper use of medications, can lead to better disease control, decrease disease-related complications, and improve overall health. Pharmacists have been shown to positively affect chronic disease outcomes through medication therapy management (MTM). The primary objectives of this project are to increase the number of patients with (1) A1c in control and (2) blood pressure in control; secondary objectives are to (3) describe number and type of medication-related problems identified and resolved by pharmacists providing MTM in Federally Qualified Health Centers (FQHCs), (4) identify potential (pADEs) and actual adverse drug events (ADEs), and refer patients to diabetes self-management education classes, as needed. Methods: This multisite, prospective, descriptive pilot study engaged three FQHC sites with distinct models of established pharmacist MTM services to care for patients with uncontrolled diabetes and/or hypertension. Data were reported in aggregate regarding primary and secondary outcomes. Results: As of December 2015, 706 patients were enrolled in the project. Of the 422 with uncontrolled diabetes, 52.84% (n = 223) had an A1c
ISSN:2150-1327
2150-1319
2150-1327
DOI:10.1177/2150131917701797